Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cyclerion Therapeutics (CYCN) Exchange Rate Effect (2019 - 2024)

Cyclerion Therapeutics has reported Exchange Rate Effect over the past 6 years, most recently at -$2000.0 for Q2 2024.

  • Quarterly results put Exchange Rate Effect at -$2000.0 for Q2 2024, down 166.67% from a year ago — trailing twelve months through Mar 2025 was -$2000.0 (down 166.67% YoY), and the annual figure for FY2024 was -$6000.0, down 175.0%.
  • Exchange Rate Effect for Q2 2024 was -$2000.0 at Cyclerion Therapeutics, up from -$4000.0 in the prior quarter.
  • Over the last five years, Exchange Rate Effect for CYCN hit a ceiling of $8000.0 in Q4 2022 and a floor of -$12000.0 in Q2 2020.
  • Median Exchange Rate Effect over the past 5 years was $1000.0 (2021), compared with a mean of $142.86.
  • Biggest five-year swings in Exchange Rate Effect: surged 400.0% in 2023 and later crashed 500.0% in 2024.
  • Cyclerion Therapeutics' Exchange Rate Effect stood at $3000.0 in 2020, then changed by 0.0% to $3000.0 in 2021, then skyrocketed by 166.67% to $8000.0 in 2022, then crashed by 50.0% to $4000.0 in 2023, then plummeted by 150.0% to -$2000.0 in 2024.
  • The last three reported values for Exchange Rate Effect were -$2000.0 (Q2 2024), -$4000.0 (Q1 2024), and $4000.0 (Q4 2023) per Business Quant data.